Effects of thrice weekly nocturnal hemodialysis on arterial stiffness

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 477-485

  Demirci, Meltem Sezis ^a   Celik, Gulperi ^b   Ozkahya, Mehmet ^a   Tumuklu, Murat ^c   Toz, Huseyin ^a   Asci, Gulay ^a   Duman, Soner ^a   Basci, Ali ^a   Kircelli, Fatih ^a   Ozdogan, Oner ^d   Demirci, Cenk ^a   Can, Levent ^a   Isik, Ismet Onder ^e   Ok, Ercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Selcuklu Faculty of Medicine   (Turkey)

^c KENT HOSPITAL   (Turkey)

^d Tepecik Research and Training Hospital ^*  (Turkey)

^e Fresenius Medical Care   (Turkey)

Author keywords

Arterial stiffness; Hemodialysis; Nocturnal dialysis

Indexed keywords

CALCIUM; PHOSPHORUS;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CAROTID ARTERY PULSE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PULSE WAVE; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CIRCADIAN RHYTHM; ELASTICITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PULSATILE FLOW; RADIAL ARTERY; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 84855971104     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.015     Document Type: Article

References (39)

1. Nichols W.W., O'Rourke M.F. Vascular impedance. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles 1998, Edward Arnold, London, UK, p. 54-97, 243-83, 347-95. 4th ed.
2. London G.M., Guerin A.P., Marchais S.J., et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996, 50:600-608.
3. London G.M., Marchais S.J., Safar M.E., et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990, 37:137-142.
4. Barenbrock M., Spieker C., Laske V., et al. Studies of the vessel wall properties in hemodialysis patients. Kidney Int 1994, 45:1397-1400.
5. Madhavan S., Ooi W.L., Cohen H., Alderman M.H. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994, 23:395-401.
6. London G.M., Marchais S.J., Guerin A.P., Metivier F., Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 2002, 17:1713-1724.
7. Lehmann E.D. Pulse wave velocity as a marker of vascular disease. Lancet 1996, 348:741-744.
8. Mattace-Raso F.U., van der Cammen T.J., Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 2006, 113:657-663.
9. Laurent S., Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease?. J Nephrol 2007, 20(12 Suppl.):S45-S50.
10. Covic A., Haydar A.A., Bhamra-Ariza P., Gusbeth-Tatomir P., Goldsmith D.J. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005, 18:388-396.
11. Ie E.H., De Backer T.L., Carlier S.G., et al. Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens 2005, 19:439-444.
12. Ichihara A., Hayashi M., Ryuzaki M., Handa M., Furukawa T., Saruta T. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002, 17:1513-1517.
13. Suzuki H., Nakamoto H., Okada H., Sugahara S., Kanno Y. A selective angiotensin receptor antagonist, valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003, 19:59-66.
14. Mahmud A., Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002, 15:321-325.
15. Tycho Vuurmans J.L., Boer W.H., Bos W.J., Blankestijn P.J., Koomans H.A. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 2002, 13:177-183.
16. Ichihara A., Hayashi M., Kaneshiro Y., et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005, 45:866-874.
17. Covic A., Goldsmith D.J., Gusbeth-Tatomir P., Buhaescu I., Covic M. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003, 76:1573-1577.
18. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007, 298:1291-1299.
19. Trial Group F.H.N., Chertow G.M., Levin N.W., Beck G.J., et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010, 363:2287-2300.
20. Ok E., Duman S., Asci G., et al. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant 2011, 26:1287-1296.
21. Lang R.M., Bierig M., Devereux R.B., et al. Chamber Quantification Writing Group. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography. J Am Soc Echocardiogr 2005, 18:1440-1463.
22. Sahn D.J., DeMaria A., Kisslo J., Weyman A. The Committee on M-mode Standardizations of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
23. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55:613-618.
24. Leypoldt J.K., jabber B.L., Zimmerman D.L. Predicting treatment dose for novel therapies using standard Kt/V. Semin Dial 2004, 17:142-145.
25. Chan C.T., Harvey P.J., Picton P., Pierratos A., Miller J.A., Floras J.S. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003, 42:925-931.
26. LeBeouf A., Mac-Way F., Utescu M.S., et al. Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant 2009, 24:3788-3794.
27. Mucsi I., Hercz G., Uldall R., Ouwendyk M., Francoeur R., Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998, 53:1399-1404.
28. Pierratos A., Ouwendyk M., Francoeur R., et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998, 9:859-868.
29. Bugeja A., Dacouris N., Thomas A., et al. In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:778-783.
30. Lacson E., Wang W., Lester K., Ofsthun N., Lazarus J.M., Hakim R.M. Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 2010, 5:220-226.
31. Demirci C., Ozkahya M., Yilmaz M., et al. Improvement in volume and nutrition status detected by bioimpedance analysis in 8h thrice weekly hemodialysis. NDT plus 2008, 1(Suppl.):ii179.
32. Nichols W.W., O'Rourke M.F. McDonald's blood flow in arteries: theoretical, experimental and clinical principles 2005, Hodder Arnold. 5th edition.
33. Buckberg G.D., Fixler D.E., Archie J.P., Hoffman J.I. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 1972, 30:67-81.
34. Ferro G., Duilio C., Spinelli L., Liucci G.A., Mazza F., Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 1995, 92:342-347.
35. London G.M., Guérin A.P., Marchais S.J., et al. Cardiac and arterial interactions in endstage renal disease. Kidney Int 1996, 50:600-608.
36. Rostand S.G., Gretes J.C., Kirk K.A., Rutsky E.A., Andreoli T.E. Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979, 16:600-611.
37. Rostand S.G., Kirk K.A., Rutsky E.A. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 1982, 22:304-308.
38. Di Iorio B.R., Cucciniello E., Alinei P., Torraca S. Reproducibility of regional pulse-wave velocity in uremic subjects. Hemodial Int 2010, 14:441-446.
39. Hajsadeghi F., Ahmadi N., Moshrefi S., et al. Increases vascular stiffness is associated with the presence and severity of coronary artery disease. J Am Coll Cardiol 2011, 57:1484. 10.1016/S0735-1097(11)61484-8.